Curaleaf Holdings (CURLF) Invested Capital (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Invested Capital of $156.1 million for Q4 2025, down 3.43% year-on-year from $161.7 million in Q4 2024, and down 3.43% on a QoQ basis from $161.7 million in Q4 2024.

Curaleaf Holdings (CURLF) Invested Capital (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Invested Capital for 7 consecutive years, with $156.1 million the latest figure, recorded in Q4 2025.

  • Quarterly Invested Capital fell 3.43% year-over-year to $156.1 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $156.1 million (down 11.82% YoY) and the FY2025 annual result came in at $156.1 million, down 3.43% from the prior year.
  • Invested Capital declined to $156.1 million in Q4 2025 per CURLF's latest filing, from $161.7 million in the prior quarter.
  • Over the last five years, Invested Capital for CURLF reached as high as $28.8 billion in Q1 2022 and fell as low as $4.2 million in Q1 2021.
  • A 5-year average of $2.0 billion and a median of $23.5 million in 2022 frame the typical range for Invested Capital.
  • Annual changes were most pronounced in 2022 — Invested Capital soared 686926.0% — and 2024, when it slumped 90.82%.
  • Year by year, Invested Capital stood at $9.2 million in 2021, then soared by 1819.73% to $175.8 million in 2022, then fell by 3.62% to $169.4 million in 2023, then dropped by 4.55% to $161.7 million in 2024, then decreased by 3.43% to $156.1 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods registered $156.1 million, $161.7 million, and $5.7 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 1.11 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 2.61 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 31.13 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 7.15 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.93 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 73.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 156.13 Mn
Dec 31, 2024 161.68 Mn
Sep 30, 2024 5.71 Mn
Jun 30, 2024 9.67 Mn
Dec 31, 2023 169.39 Mn
Sep 30, 2023 62.25 Mn
Jun 30, 2023 48.47 Mn
Dec 31, 2022 175.75 Mn
Sep 30, 2022 23.48 Mn
Jun 30, 2022 20.96 Mn
Mar 31, 2022 28.81 Bn
Dec 31, 2021 9.16 Mn
Sep 30, 2021 9.16 Mn
Jun 30, 2021 9.16 Mn
Mar 31, 2021 4.19 Mn
Dec 31, 2020 6.50 Mn
Sep 30, 2020 9.70 Mn
Dec 31, 2019 17.00 Mn